Classification
Product TypeProcessed Food
Product FormOral dietary supplement (capsules/tablets/softgels/powder)
Industry PositionFinished Dietary Supplement Product
Market
In Brazil, biotin supplements are regulated as “suplementos alimentares” under ANVISA’s food framework, with composition, safety, and labeling requirements anchored in RDC 243/2018 and the complementary constituent/limits/claims lists in IN 28/2018. Biotin (D-biotin) is included in the authorized constituent lists, and authorized claim wording exists (e.g., metabolism support and maintenance of hair and skin) when the product meets the applicable composition conditions and limits. Market access risk is driven less by agronomic seasonality and more by regulatory compliance (constituent eligibility, dosage limits by population group, and strict claim/label controls). Imports and domestically manufactured/packed products both need to align with ANVISA’s sanitary requirements and, for import operations, the applicable government trade licensing/document workflows (e.g., LI/LPCO models in the Portal Único Siscomex context for food imports).
Market RoleDomestic consumer market with both imports and local manufacturing/packing
Domestic RoleConsumer-packaged supplement positioned around ANVISA-authorized biotin functions/claims (within the authorized wording and compositional conditions)
Specification
Physical Attributes- Products are presented in oral ‘pharmaceutical forms’ (e.g., capsules/tablets), consistent with ANVISA’s definition of suplemento alimentar and the required product designation format.
Compositional Metrics- The daily recommended intake on label must comply with the minimum and maximum limits defined in the applicable annexes of IN 28/2018 for the indicated population group(s), as required by RDC 243/2018.
Packaging- Portuguese labeling is central to acceptance: the product must be designated as “Suplemento Alimentar” plus its dosage form, and the label must include required warnings such as “Este produto não é um medicamento”, “Não exceder a recomendação diária de consumo indicada na embalagem”, and “Mantenha fora do alcance de crianças”, per RDC 243/2018.
Supply Chain
Value Chain- Active ingredient (biotin) sourcing and qualification → receipt and identity/purity checks against accepted references → blending with permitted excipients → encapsulation/tableting → packaging and label control → finished-product release (documentation retained for authority review) → distribution through regulated retail channels and/or import clearance flow when imported
Temperature- While biotin solid-dose supplements are typically less cold-chain dependent than fresh foods, stability through shelf-life must be ensured via stability studies and appropriate conservation instructions, as required by RDC 243/2018.
Shelf Life- Shelf-life claims must be supported by stability studies and quality controls, with documentation retained for competent authority consultation, per RDC 243/2018.
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighNon-compliance with ANVISA’s supplement framework (RDC 243/2018 + IN 28/2018 lists/limits/authorized claims) can result in import delay, refusal, enforcement action, or market withdrawal—especially where biotin dosage, population-group limits, or claim wording/conditions do not match the authorized rules.Pre-validate formulation, daily intake, and all biotin-related label claims against RDC 243/2018 and the current IN list(s); keep a complete compliance dossier ready for authority review (specifications, stability rationale, labeling rationale).
Food Safety MediumDietary supplements face elevated scrutiny for contamination/adulteration risk; RDC 243/2018 explicitly disallows doping-listed and controlled substances in supplement composition, creating a high-impact compliance failure mode if suppliers are not tightly qualified.Implement supplier qualification and batch testing (identity, purity, contaminants) and require robust CoA and change-control; apply risk-based screening for prohibited substances where relevant.
Documentation Gap MediumBrazil’s import workflow for foods under sanitary intervention can involve LI/LPCO models and protocol steps that change over time; misaligned filings, fee-payment linkage issues, or incomplete submissions can create clearance delays and storage-cost escalation.Use an experienced customs broker familiar with ANVISA food-import LPCO requirements; track current Siscomex/ANVISA notices on LPCO model usage and fee-payment integration; reconcile product classification and dossier completeness before shipment.
FAQ
Can a biotin supplement in Brazil claim benefits for hair and skin?Yes—ANVISA’s IN 28/2018 includes authorized biotin-related claim wording (including maintenance of hair and skin), but the claim is conditional on meeting the rule’s compositional requirements and staying within the applicable minimum and maximum limits for the labeled daily intake.
What label warnings are mandatory for supplements in Brazil?RDC 243/2018 requires that supplements be designated as “Suplemento Alimentar” plus the dosage form and include mandatory warnings such as “Este produto não é um medicamento”, “Não exceder a recomendação diária de consumo indicada na embalagem”, and “Mantenha fora do alcance de crianças”.
Are doping substances allowed in Brazilian dietary supplements?No. RDC 243/2018 prohibits substances considered doping by WADA and substances subject to special control rules (as referenced by the regulation), so products and raw materials must be qualified to avoid prohibited-substance risk.